The Federal Communications Commission (FCC) is urging broadcasters to air more "patriotic, pro-America" content in honor of the 250th anniversary of the signing of the Declaration of Independence. In ...

Inside an unassuming building in Winnipeg's core, a small team is working to protect people from dangerous street drugs. Main Street Project's safe supply program provides those addicted primarily to ...

Federal Communications Commission Chair Brendan Carr is urging broadcast media companies to air “patriotic, pro-America content” in a new campaign aligned with President Donald Trump’s Freedom 250 ...

Students said the idea for the project started about two years ago. BBC hits back in Trump's $10 billion lawsuit US judge throws out immigration board's ruling endorsing Trump mass detention policy ...

When students talk about the ability to take Running Start courses during the summer, they don’t talk about credits; they talk about opportunity. For one high school student, enrolling in a summer ...

Without a doubt, one of the hottest new startup accelerators in tech right now is Andreessen Horowitz’s Speedrun program. Launched in 2023, the accelerator has an acceptance rate of less than 1%. In a ...

Social Security, which provides benefits to about 70 million Americans, could run out of money sooner than expected, according to a new report from the Congressional Budget Office. The Old-Age and ...

TURKU, Finland, Feb. 10, 2026 /PRNewswire/ -- Vaadin, the leading provider of Java web application frameworks, today announced the general availability of Swing Modernization Toolkit, a solution that ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Fullerton has launched its new city-operated ambulance transportation program. Under the model, fire personnel will manage the full emergency response, from initial patient contact to transport to a ...

Amgen has terminated its rocatinlimab collaboration with Kyowa Kirin, walking away from the anti-OX40 antibody five years after paying $400 million for rights to the autoimmune disease drug candidate.